Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jasper Therapeutics

5.26
-0.1500-2.77%
Post-market: 5.260.00000.00%18:44 EDT
Volume:172.16K
Turnover:919.36K
Market Cap:79.02M
PE:-1.00
High:5.51
Open:5.41
Low:5.23
Close:5.41
Loading ...

Promising Efficacy and Safety in Jasper Therapeutics’ SPOTLIGHT Trial Supports Buy Rating

TIPRANKS
·
17 Jun

Jasper Therapeutics Shares Rise on Positive Data From Recent Study

Dow Jones
·
16 Jun

William Blair Remains a Buy on Jasper Therapeutics (JSPR)

TIPRANKS
·
16 Jun

Jasper Therapeutics presents data from SPOTLIGHT Phase 1b/2a study

TIPRANKS
·
16 Jun

Jasper Therapeutics Reports Positive Data From 180Mg Cohort in Spotlight Study of Briquilimab in Chronic Inducible Urticaria

THOMSON REUTERS
·
14 Jun

Jasper Therapeutics Unveils New Insights on Briquilimab's Efficacy in Mast Cell Mediated Diseases

Reuters
·
21 May

Jasper Therapeutics Is Maintained at Buy by UBS

Dow Jones
·
14 May

RBC Adjusts Price Target on Jasper Therapeutics to $46 From $48, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
13 May

Jasper Therapeutics Inc : UBS Cuts Target Price to $33 From $38

THOMSON REUTERS
·
13 May

Jasper Therapeutics Faces Financial Challenges Amid Rising R&D Costs

TIPRANKS
·
13 May

Jasper Therapeutics reports Q1 EPS ($1.41), consensus ($1.48)

TIPRANKS
·
13 May

Jasper Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Jasper Therapeutics Q1 EPS $(1.41) Misses $(1.33) Estimate

Benzinga
·
13 May

Jasper Therapeutics Q1 Income From Operation USD -21.802 Million

THOMSON REUTERS
·
13 May

Jasper Therapeutics Q1 EPS USD -1.41

THOMSON REUTERS
·
13 May

Jasper Therapeutics Inc expected to post a loss of $1.31 a share - Earnings Preview

Reuters
·
09 May

BRIEF-Jasper Therapeutics Inc Files For Common Stock Offering Of Up To $100 Million - SEC Filing

Reuters
·
27 Mar

Jasper Therapeutics Files $300 Million Mixed Shelf

MT Newswires Live
·
20 Mar

Jasper Therapeutics Signs New Sales Agreement with Jefferies

TIPRANKS
·
20 Mar

BRIEF-Jasper Therapeutics terminates Cantor sales agreement

Reuters
·
20 Mar